Chapters:
0:00 Novel Cas enzymes help overcome CRISPR challenges
11:37 New pipeline of therapies will go after novel targets
14:52 How does the new platform open up possibilities for new diagnostics?
21:05 What risks do you think about?
26:47 What are the company’s two-year goals?
31:07 On the possibilities
CRISPR technology is enabling a new generation …
Next Gen CRISPR Therapies with Trevor Martin, CEO of Mammoth Biosciences
www.mendelspod.com
Next Gen CRISPR Therapies with Trevor Martin, CEO of Mammoth Biosciences
1×
Mendelspod Podcast
Offering a front row seat to the Century of Biology, veteran podcast host Theral Timpson interviews the who's who in genomics and genomic medicine.
Listen on
Substack App
Apple Podcasts
RSS Feed
Appears in episode
Theral Timpson
Next Gen CRISPR Therapies with Trevor Martin, CEO of Mammoth Biosciences
Comments on this episode are for paid subscribers